References
- Murphy S. Hand H. Rosenthal D. Laszlo J. Essential thrombocythemia: an interim repoit from the polycythemia vera study group. Sem Hematol 1986; 23: 177–82.
- Zahavi J, Zahavi M. Firstetcr E. Frish B. Turleanu R, Rachmani R. An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications. Eur J Haematol 1991; 47: 326–32.
- Kwong Y L. Liang R H S, Chiù E K W, Lie A K W. Chan L C. Todd D, Chan T K. Essential thrombocythemia: A retrospective analysis of 39 cases. Am J Hematol 1995; 49: 39–42.
- Randi Ml. Stocco F. Rossi C, Tison T, Giratami A. Thrombosis and haemorrhage in thrombocytosis. Evaluation of a large cohort of patiente (357 cases). J M ed 1991; 22: 21.3–23.
- ilus/.ka M. Káplár M, Rcjto I. Tornai I, Palatka K. Laszlo l\ Udvardy M. The association of reduced endothelium derived relaxing factor-NQ production with endothelial damage and increased in vivo platelet activation in patients with diabetes mcllitus. Thromb ties 1997; 86: 173–80.
- Udvardy M, Káplãr M. Rejtò L. Tornai 1, Palatka K. Laszlo P. Huszka M. Increased in vivo platelet uclivalion and reduced intravascular cndothclium-derived relaxing factor and nitrate/ nitrite production in patients with insuhn-dependent diabetes mcllitus. Platelets 1998; 9: 257–60.
- Moneada S. Palmer R M J. Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991:43: 109–42.
- Mumgiinandnm A. Mutus B. Isolation of nitric oxide synthase from human platelets. Biochimica et Biop/iysica Acia 1994; 1200: 1 6.
- Sase K. Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 1995; 57: 2049–55.
- Mehta J L Chen L Y, Kone C B, Menta P, Turner P. Identification o\’ constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 1995; 125: 370–77.
- Zhou Q, Hellcrmann G R. Solomonson L P. Nitric oxide release from resting human platelets. Thromb Res 1995; 77: 87–96.
- Frccdman J E. Loscalzo J, Barnard M R. Alpert C. Keancy J F, Michelson A D. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1977; 100: 350–56.
- Malinski T, Radomski M W, Taha Z. Moneada S Direct electrochemical measurement of nitric oxide released from human platelets Biochem Biaphvs Res Cumimm 1993; 194: 960 65.
- Radomski M W. Zakar T. Salas E. Nitric oxide in platelets. Meih Enzymol 1996; 269: 88–107.
- Radomski M W. Palmer R M J. Moneada S. An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl Acad Sci 1990; 87: 5193–97.
- Bcrkels R. Stockklauser K. Rosen P. Rosen R. Current status on platelet NO synthases. Thromb Res 1997; 87: 51–5.
- Gordge M P. Neild G H. Platelets from patients on haemodialysis show impaired responses to nitric oxide. Clin Sci 1992;83:313–18.
- Cadwagn T M. Benjamin N. Evidence for altered platelet nitric oxide synlhesis in essential hypertension. J Hypertension 1993; 11:417–20.
- Berlini N 1. Diagnosis and classification of the polycythemias. Semùì Hematol 1975; 12: 339 51.
- Murphy S. Peterson P, Hand H. Laszlo J. Experience of the polycythemia vera study group with essential ihrombocythcmia; a final report on diagnostic criteria, survival, and leukemic transition by treatment. Sem Hematol 1997; 34: 29–39.
- Nowell P C. Hungerford D A. A minute chromosome in human crauuloevlic leukemia. Science 1960; 132: 1497–99.
- Rowley J D. A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining Nature 1973; 243: 290–93.